Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

QLT INC T.QLT

Healthcare Biotechnology
"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."


TSX:QLT - Post by User

QLT INC
Bullboard Posts
User Avatar Image
(88)
•••
Post by Daregon Oct 04, 2000 1:26pm
544 Views
Post# 2602869

QLT Upgrade

QLT Upgrade StockAlert: Movers/News Latest Analyst Upgrades / Downgrades (11:52 EST) QLT Inc. [T.QLT] -$15.15 to $82.35 QLT was raised to a "strong buy" from "accumulate" by analyst Ezra Lwowski at Yorkton Securities. The 12 to 18-month target price is $134 a share.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities